This site is intended for health professionals only

Published on 23 October 2012

Share this story:

RELATED ARTICLES
Join us for new Clinical Excellence in Respiratory Care event
Dismayed reactions from sector over proposed GPhC fees increase
Dapagliflozin use in heart failure extended by NICE to reduce hospitalisations
Study confirms spironolactone safe and effective for treating acne in women
Calls for HCPs to respond to major conditions strategy consultation

Orion Group interim report, January-September 2012

teaser

Orion’s net sales for January-September 2012 totalled €726 million (€682 million for January-September 2011), up by 7% on the comparative period last year. To view the report, please click on the link below:


Most read

1
Oral vitamin A could become an alternative to isotretinoin for acne
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Launch of the new Hospital Pharmacy Europe Mobile App



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
Pharma firms and research organisations ‘divided’
SMC recommendation of self-injection formulation of abatacept
bioProcessUK welcomes investment in bioprocessing research
Bevacizumab breast cancer therapy stalled in UK
Need to improve easy access to HIV pre-exposure prophylaxis
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2024
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x